Pierluigi Vito Amadori

Learn More
Undetermined thyroid cytology precludes any definitive distinction between malignant and benign lesions. Recently several classifications have been proposed to split this category into two or more cytological subcategories related to different malignancy risk rates. The current study was performed retrospectively to investigate the results obtained(More)
MacroPRL can be due either to anti-PRL autoantibodies IgG (IgG-macroPRL) or other PRL containing molecules without IgG-PRL immuncomplexes (nIgG-macroPRL), the composition of which is not fully clarified. The aims of this study were: a) testing a new immunometric assay, capable of recognising IgG-macroPRL, b) looking for any biological and/or clinical(More)
We introduce a new approach to constant-envelope precoding (CEP) based on an interference-driven optimization region for generic phase-shift-keying modulations in the multiuser (MU) multiple-input-multiple-output downlink. While conventional precoding approaches aim to minimize the multi-user interference (MUI) with a total sum-power constraint at the(More)
B-RAF V600E mutation is frequently observed in several tumors, including papillary thyroid carcinomas (PTCs), where it is considered of potential diagnostic and prognostic value. The reported prevalence of B-RAF mutation in PTCs in different Italian populations varies from 14% to 69%. The authors investigate the prevalence and utility of the B-RAF V600E(More)
All the studies on hyperprolactinemia should not forget to consider the possible presence of macroprolactinemia Pierluigi Amadori, Costantino Dilberis and Alberto Marcolla Outpatient Endocrinology Service, Azienda Provinciale per i Servizi Sanitari, Trento, Italy, Laboratory of Clinical Analysis, S. Camillo Hospital, Trento, Italy and Clinical Chemistry(More)
Prolactin (PRL) in human serum is present in three species: monomeric PRL (23 kDA), big PRL (50-60 kDa) and big, big PRL (bb-PRL or macroprolactinemia) of 150-170 kDa. Macroprolactin seems to be mainly composed of a molecule of monomeric PRL and an immunoglobulin G anti PRL. Its biological activity is considered low or absent, but it is measured, at various(More)